Equibal Inc
FDA inspection history in Unionville, New York, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Unionville, New York.
Cited most
Across all Equibal observations on file
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.166(a)Stability testing1
- 21 CFR 211.180(e)(2)General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.198(a)Complaint files1
The complete Equibal file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Unionville, New York
One Form 483 · 2024 · 11 observations
Latest: Form 483, May 30, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-05-30 | 483 Form 483 | Unionville, New York | 11 | $99 |
Investigators on these documents
Ifechimere I. Okafor (1)Paige R. McCoy (1)Pushpa S. Jayasekara (1)
FEI number 3003440513 · most recent document May 30, 2024
About Equibal Inc
How many FDA Form 483s has Equibal Inc received?
FDA Intel has 1 Form 483 on file for Equibal Inc; the most recent is dated May 30, 2024.
When was Equibal Inc last inspected by FDA?
The most recent FDA inspection document on file for Equibal Inc is a Form 483 dated May 30, 2024, for the site in Unionville, New York.
What did FDA cite at Equibal Inc?
The regulations cited most in the observations on file for Equibal Inc are 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.166(a) (Stability testing), 1 time; 21 CFR 211.180(e)(2) (General requirements), 1 time.